Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARHGAP31 antisense RNA 1 (ARHGAP31-AS1)
- Target
- ARHGAP31-AS1
- Molecular classification
- Other (long non-coding RNA, lncRNA)
01
Overview
ARHGAP31 antisense RNA 1 (ARHGAP31-AS1) is a long non-coding RNA gene located on human chromosome 3. It is transcribed from the antisense strand adjacent to the ARHGAP31 gene, but its biological function is uncharacterized in the published literature and major gene function databases. There is currently no evidence linking ARHGAP31-AS1 to specific cell biological roles, molecular pathways, disease associations, or pharmacology[3][6][9]. Its annotation reflects only its genomic position and antisense relationship to ARHGAP31, a well-characterized Rho GTPase-activating protein linked to cytoskeletal organization and Adams-Oliver syndrome. If a specific biological or clinical role is discovered in the future, classification may change, but based on current data, ARHGAP31-AS1 is a non-protein-coding lncRNA of unknown biological function.
- Other names
- ARHGAP31 antisense RNA 1 (non-protein coding)ARHGAP31-AS1
02
Mechanism of action
None reported
03
Biological functions
There is currently no published evidence on well-established biological functions, molecular roles, or mechanisms for ARHGAP31-AS1. Long non-coding RNAs generally function in transcriptional and epigenetic regulation, RNA processing, and chromatin remodeling, but whether ARHGAP31-AS1 directly regulates ARHGAP31 or other targets remains unreported in the available literature.
04
Disease associations
No reported links to specific diseases or pathogenic functions. Research on ARHGAP31 (the protein-coding gene) associates it with Adams-Oliver syndrome, but there is no evidence to date implicating ARHGAP31-AS1 in any disease.
Beyond the preview
Go deeper on ARHGAP31 antisense RNA 1 (ARHGAP31-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ARHGAP31 antisense RNA 1 (ARHGAP31-AS1).